Found 4 matching trials
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
PHASE3The objective of this study is to evaluate the safety and efficacy of GV100...
Location
Multiple Locations
Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011
PHASE2The study will be conducted by the Sponsor to evaluate Twelve-months Long-T...
Location
Seoul National University Bundang Hospital
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
PHASE2The current study is being conducted by the Sponsor to evaluate the efficac...
Location
First Choice Neurology - Aventura Neurologic Associates
GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)
PHASE2The study will be conducted by the Sponsor to evaluate the efficacy and saf...
Location
Seoul National University Bundang Hospital